20/20 Biolabs Inc (AIDX)

$0.52 -0.03 (-6.21%)
Market Cap 6.74M
Revenue (ttm) 2.05M
Net Income (ttm) -3.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -182.44%
Debt to Equity Ratio 0.11
Volume 75,100
Avg Vol 790,358
Day's Range N/A - N/A
Shares Out 12.25M
Stochastic %K 54%
Beta N/A
Analysts Strong Sell
Price Target $5.00

Company Profile

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name t...

Industry: Medical Devices
Sector: Healthcare
Phone: (240) 453-6339
Address:
15810 Gaither Road, Suite 235, Gaithersburg, United States
focafoca99
focafoca99 Aug. 19 at 1:27 PM
$AIDX held its annual meeting, electing six directors and approving an equity incentive plan.
0 · Reply
Lonestardom
Lonestardom Aug. 17 at 1:31 PM
$AIDX — 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level https://finance.yahoo.com/healthcare/articles/20-20-biolabs-reports-second-123100859.html
0 · Reply
STACKD0E
STACKD0E Aug. 17 at 12:53 PM
$AIDX $DRMA $CSAI $NCTY 👀
0 · Reply
focafoca99
focafoca99 Aug. 17 at 12:46 PM
$AIDX comments on Q2 2026 results, reporting $0.7M revenue, 47% YoY growth, and Series E financing that eliminated convertible note debt.
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 17 at 12:34 PM
$AIDX 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
0 · Reply
Gairbear
Gairbear Aug. 13 at 6:48 PM
$AIDX building up for a run
0 · Reply
TheOrangeBall
TheOrangeBall Aug. 12 at 6:37 PM
$AIDX Loading. Expecting a pump.
0 · Reply
MarketMaven59
MarketMaven59 Jul. 28 at 1:30 PM
$AIDX — 20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy https://finance.yahoo.com/healthcare/articles/20-20-biolabs-participates-bio-203000683.html
0 · Reply
showmethemoney75
showmethemoney75 Jul. 28 at 1:26 PM
$AIDX They have diluted the crap out of this
0 · Reply
showmethemoney75
showmethemoney75 Jul. 28 at 1:26 PM
$AIDX Looks like .30s today
0 · Reply
Latest News on AIDX
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

Aug 17, 2026, 8:31 AM EDT - 2 days ago

20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management's Recent East Asia Business Development Tour

Jul 30, 2026, 8:31 AM EDT - 20 days ago

20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management's Recent East Asia Business Development Tour

20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy

Jul 27, 2026, 4:30 PM EDT - 22 days ago

20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy

20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

Jul 23, 2026, 8:31 AM EDT - 27 days ago

20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth

Jul 9, 2026, 4:01 PM EDT - 5 weeks ago

20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

Jun 22, 2026, 4:45 PM EDT - 2 months ago

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters

May 27, 2026, 8:31 AM EDT - 3 months ago

20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters

20/20 BioLabs develops contingency plans to establish Ebola, Hantavirus

2026-05-22T12:48:59.000Z - 3 months ago

20/20 BioLabs develops contingency plans to establish Ebola, Hantavirus

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

May 22, 2026, 8:31 AM EDT - 3 months ago

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress

May 20, 2026, 4:05 PM EDT - 3 months ago

20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026

May 14, 2026, 8:31 AM EDT - 3 months ago

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026

20/20 BioLabs enters licensing agreement with University of South Carolina

2026-05-12T14:02:02.000Z - 3 months ago

20/20 BioLabs enters licensing agreement with University of South Carolina

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

May 12, 2026, 8:31 AM EDT - 3 months ago

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

20/20 BioLabs initiated with a Buy at Maxim

2026-05-11T15:28:33.000Z - 3 months ago

20/20 BioLabs initiated with a Buy at Maxim

20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform

Apr 7, 2026, 8:31 AM EDT - 4 months ago

20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform

20/20 BioLabs files to sell 10.1M shares of common stock for holders

2026-04-06T21:35:08.000Z - 4 months ago

20/20 BioLabs files to sell 10.1M shares of common stock for holders

20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress

Mar 31, 2026, 4:57 PM EDT - 5 months ago

20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress

20/20 BioLabs announces grants for Maryland fire departments to procure OneTest

2026-03-27T12:57:40.000Z - 5 months ago

20/20 BioLabs announces grants for Maryland fire departments to procure OneTest

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest ™ Multi-Cancer Early Detection Blood Test

Mar 27, 2026, 8:31 AM EDT - 5 months ago

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest ™ Multi-Cancer Early Detection Blood Test

20/20 BioLabs enters exclusive technology license, access agreement with Rokit

2026-03-24T12:46:06.000Z - 5 months ago

20/20 BioLabs enters exclusive technology license, access agreement with Rokit

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

Mar 24, 2026, 8:31 AM EDT - 5 months ago

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

20/20 BioLabs provides update on protein biomarket technology for MCED

2026-03-12T12:50:29.000Z - 5 months ago

20/20 BioLabs provides update on protein biomarket technology for MCED

20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies

Mar 12, 2026, 8:31 AM EDT - 5 months ago

20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies

20/20 Biolabs, Inc. Common Stock trading resumes

2026-02-25T15:10:13.000Z - 6 months ago

20/20 Biolabs, Inc. Common Stock trading resumes

20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause

2026-02-25T15:00:36.000Z - 6 months ago

20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause

20/20 BioLabs announces launch, commercial availability of OneTest

2026-02-25T13:54:37.000Z - 6 months ago

20/20 BioLabs announces launch, commercial availability of OneTest

20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities

Feb 25, 2026, 8:31 AM EST - 6 months ago

20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities

20/20 Biolabs, Inc. Common Stock trading resumes

2026-02-23T14:40:15.000Z - 6 months ago

20/20 Biolabs, Inc. Common Stock trading resumes

20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause

2026-02-23T14:35:36.000Z - 6 months ago

20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause

20/20 Biolabs IPO Registration Document (S-1)

Dec 12, 2025, 5:19 PM EST - 8 months ago

20/20 Biolabs IPO Registration Document (S-1)

focafoca99
focafoca99 Aug. 19 at 1:27 PM
$AIDX held its annual meeting, electing six directors and approving an equity incentive plan.
0 · Reply
Lonestardom
Lonestardom Aug. 17 at 1:31 PM
$AIDX — 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level https://finance.yahoo.com/healthcare/articles/20-20-biolabs-reports-second-123100859.html
0 · Reply
STACKD0E
STACKD0E Aug. 17 at 12:53 PM
$AIDX $DRMA $CSAI $NCTY 👀
0 · Reply
focafoca99
focafoca99 Aug. 17 at 12:46 PM
$AIDX comments on Q2 2026 results, reporting $0.7M revenue, 47% YoY growth, and Series E financing that eliminated convertible note debt.
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 17 at 12:34 PM
$AIDX 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
0 · Reply
Gairbear
Gairbear Aug. 13 at 6:48 PM
$AIDX building up for a run
0 · Reply
TheOrangeBall
TheOrangeBall Aug. 12 at 6:37 PM
$AIDX Loading. Expecting a pump.
0 · Reply
MarketMaven59
MarketMaven59 Jul. 28 at 1:30 PM
$AIDX — 20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy https://finance.yahoo.com/healthcare/articles/20-20-biolabs-participates-bio-203000683.html
0 · Reply
showmethemoney75
showmethemoney75 Jul. 28 at 1:26 PM
$AIDX They have diluted the crap out of this
0 · Reply
showmethemoney75
showmethemoney75 Jul. 28 at 1:26 PM
$AIDX Looks like .30s today
0 · Reply
Huskersnsaints
Huskersnsaints Jul. 28 at 8:31 AM
$AIDX another positive PR And this will be trading below .40
0 · Reply
Stocks4Sophia
Stocks4Sophia Jul. 23 at 1:31 PM
$AIDX — 20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock https://finance.yahoo.com/healthcare/articles/20-20-biolabs-announces-standstill-123100857.html
0 · Reply
RalphyFields
RalphyFields Jul. 10 at 1:30 PM
$AIDX — 20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth https://finance.yahoo.com/healthcare/articles/20-20-biolabs-highlights-investor-200100817.html
0 · Reply
Lyn30
Lyn30 Jul. 6 at 5:55 PM
$AIDX this should run huge imo As usual all may come with rocket and I may sell at that time . Analyst pt $5 Float 10M U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts 20/20 Biolabs' OneTest Multi-Cancer Early Detection Blood Test Selected As Part Of Firefighter Cancer Screening Initiative For State Of Vermont In Partnership With National Diagnostic Services
0 · Reply
Lyn30
Lyn30 Jul. 6 at 4:58 PM
$AIDX Float 10M 52 weeks high $50 It may run soon🚀🚀🚀🚀
0 · Reply
TradPoof
TradPoof Jul. 6 at 12:26 PM
$AIDX 👀 potential 💯% from here. Pending news to drop. Grab a bag 💰
0 · Reply
LongMoneyMovements
LongMoneyMovements Jul. 2 at 1:19 PM
$AIDX plan accordingly
0 · Reply
Thunder000
Thunder000 Jul. 2 at 12:55 PM
$AIDX my initial buy was $2.72 back in March. Is there any chance I can get my money back?
1 · Reply
LongMoneyMovements
LongMoneyMovements Jul. 1 at 6:07 PM
$AIDX 2026-05-15 13F Citadel Advisors Llc bought 16,227 shares https://fintel.io/so/us/aidx
1 · Reply
biotech92
biotech92 Jul. 1 at 5:49 PM
$AIDX I am usually a skeptic and realize the long odds these small companies face......but count me as beyond impressed with the presentation today. I've gone from thinking of getting out to actually wanting to build a very sizable position and move it over to a longterm account. I encourage all to go to the website and listen to this inaugural investor webinar. It is PHENOMENAL, seriously.
0 · Reply
LongMoneyMovements
LongMoneyMovements Jul. 1 at 3:01 PM
$AIDX 2026-05-15 13F Citadel Advisors Llc bought 16,227 shares https://fintel.io/so/us/aidx
0 · Reply
trader2360
trader2360 Jul. 1 at 2:47 PM
$AIDX no history of r/s this will go to $5
0 · Reply